| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-05 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-05 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.19 | 6e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-05 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-05 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.16 | 9e-05 |